We are live on
!
Find out more
Xilio Therapeutics
9.00
USD
-0.01
0.11%
At close
Updated
Aug 28, 4:00 PM EDT
Pre-market
After hours
1 day
-0.11%
5 days
-3.43%
1 month
-1.64%
3 months
5.63%
6 months
18.89%
Year to date
-4.26%
1 year
-6.93%
5 years
-95.98%
10 years
-95.98%
New
Increased
Maintained
Reduced
Closed
Mega AUM
Over $200B
Large AUM
$10B to $200B
Mid AUM
$2B to $10B
Small AUM
$250M to $2B
Micro AUM
Under $250M
Less than 10%
Less than 20%
Less than 40%
Less than 60%
Less than 80%
| # | Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|---|
| 26 |
26
UBS Group
Zurich,
Switzerland
| $134 | -$33.6K | -4,024 | -100% |
|
| 27 |
CP
27
Caligan Partners
New York
| – | -$943K | -112,128 | Closed |
|
| 28 |
AIIC
28
AJU IB Investment Company
Seoul,
South Korea
| – | -$401K | -47,695 | Closed |
|
| 29 |
29
Fidelity Investments
Boston,
Massachusetts
| – | -$307K | -36,558 | Closed |
|
| 30 |
GCM
30
Ghisallo Capital Management
Boston,
Massachusetts
| – | -$116K | -13,800 | Closed |
|
| 31 |
31
JP Morgan Chase
New York
| – | -$1.98K | -240 | Closed |
|
| 32 |
32
Vanguard Global Advisers
Malvern,
Pennsylvania
| – | -$1.77K | -210 | Closed |
|
| 33 |
33
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$1K | -91 | Closed |
|